Arterra Bioscience SpA (MIL:ARBS) ROCE % : 10.83% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Arterra Bioscience SpA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Arterra Bioscience SpA's annualized ROCE % for the quarter that ended in Jun. 2024 was 10.83%.

Arterra Bioscience SpA ROCE % Historical Data

The historical data trend for Arterra Bioscience SpA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arterra Bioscience SpA ROCE % Chart

Arterra Bioscience SpA Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

15.45

13.73

13.05

16.58

11.35

Arterra Bioscience SpA Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial									17.83	15.72	4.73	18.28	10.83

Arterra Bioscience SpA ROCE % Calculation

Arterra Bioscience SpA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1.312	/	( ( (12.569 - 1.155)	+	(12.554 - 0.843) )	/ 2 )
	=	1.312	/	( (11.414	+	11.711)	/ 2 )
	=	1.312	/	11.5625
	=	11.35 %

Arterra Bioscience SpA's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	1.266	/	( ( (12.554 - 0.843)	+	(12.541 - 0.876) )	/ 2 )
	=	1.266	/	( ( 11.711	+	11.665 )	/ 2 )
	=	1.266	/	11.688
	=	10.83 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Arterra Bioscience SpA (MIL:ARBS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Arterra Bioscience SpA ROCE % Related Terms

Thank you for viewing the detailed overview of Arterra Bioscience SpA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arterra Bioscience SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arterra Bioscience SpA (MIL:ARBS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

via Benedetto Brin, 69, Napoli, ITA, 80142

Website

https://www.arterrabio.it

Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.

Arterra Bioscience SpA Headlines

No Headlines